Article Details
Retrieved on: 2025-02-06 13:32:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a trial of individualized cancer immunotherapy using BioNTech's NeoVax vaccine, which utilizes business intelligence, such as predictive algorithms, to personalize the vaccine based on extracted tumor neoantigens, enhancing anti-cancer responses in patients.
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here